Search
Search Results
##search.searchResults.foundPlural##
-
THERAPY-RELATED MYELOID NEOPLASM IN NON-HODGKIN LYMPHOMA SURVIVORS
2695PDF: 769HTML: 2320 -
OCCURRENCE OF SECONDARY MALIGNANCIES IN CHRONIC MYELOID LEUKEMIA DURING THERAPY WITH IMATINIB MESYLATE-SINGLE INSTITUTION EXPERIENCE
2308PDF: 1075HTML: 2023Characteristic of study group: 214 -
IMPACT OF COVID-19 ON OUTCOMES OF PATIENTS WITH HEMATOLOGIC MALIGNANCIES: A MULTI-CENTER, RETROSPECTIVE STUDY COVID-19 and hematologic malignancy
1717PDF: 817HTML: 223 -
CAR-T CELL THERAPY FOR T-CELL MALIGNANCIES CAR-T CELL FOR T-CELL MALIGNANCIES
2253PDF: 2084HTML: 207 -
THERAPY-RELATED MYELOID MALIGNANCIES IN MYELOMA
2531PDF: 808HTML: 1743 -
CLONAL HEMATOPOIESIS: ROLE IN HEMATOLOGIC NON-HEMATOLOGIC MALIGNANCIES CLONAL HEMATOPOIESIS AND MALIGNANCIES
3187PDF: 940HTML: 2525 -
THE IMPORTANCE OF TARGETED NEXT-GENERATION SEQUENCING USAGE IN CYTOGENETICALLY NORMAL MYELOID MALIGNANCIES Targeted next-generation sequencing usage in cytogenetically normal myeloid malignancies
1817PDF: 583HTML: 354 -
TUBERCULOSIS IN PATIENTS WITH HAEMATOLOGICAL MALIGNANCIES
3366PDF: 1276HTML: 8386 -
TP53-MUTATED MYELODYSPLASIA AND ACUTE MYELOID LEUKEMIA TP53 in MDS and AML
2237PDF: 1762HTML: 821 -
ESCHERICHIA COLI: AN IMPORTANT PATHOGEN IN PATIENTS WITH HEMATOLOGIC MALIGNANCIES
2177PDF: 740HTML: 2143Untitled: 235Untitled: 163Untitled: 188Untitled: 167Untitled: 182Untitled: 195Untitled: 195 -
TOXICITIES ASSOCIATED WITH CAR-T CELL THERAPIES CAR-T Cell Toxicity
2418PDF: 1691HTML: 435 -
NUTRITIONALLY VARIANT STREPTOCOCCI BACTEREMIA IN CANCER PATIENTS: A RETROSPECTIVE STUDY, 1999-2014
2189PDF: 1030HTML: 4088Cover Letter: 232Figure 1: 244Figure 2: 241Table 1: 215 -
OPTIMIZING TREATMENT, MINIMIZING RISK: THERAPEUTIC DRUG MONITORING IN HEMATOLOGICAL MALIGNANCIES
1428PDF: 1660Suppl. Files: 172HTML: 87 -
TRANSCRIPTOME ANALYSIS OF BETA-CATENIN-RELATED GENES IN CD34+ HAEMATOPOIETIC STEM AND PROGENITOR CELLS FROM PATIENTS WITH AML Transcriptome analysis of beta-catenin-related genes in AML
1104PDF: 1202Suppl. Files: 581HTML: 94 -
WALDENSTROM’S MACROGLOBULINEMIA: AN UPDATE
7754PDF: 2462HTML: 2102Table 1.: 234Table 2.: 242Table 3.: 226Table 4.: 219 -
EPIDEMIOLOGY OF INVASIVE FUNGAL INFECTIONS IN THE MEDITERRANEAN AREA
2311PDF: 1005HTML: 4963 -
RARE CYTOGENETIC ABNORMALITIES IN MYELODYSPLASTIC SYNDROMES
3880PDF: 1704HTML: 11779Figures Haase: 224 -
UPDATE ON CYTOMEGALOVIRUS INFECTION MANAGEMENT IN ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS A Consensus Document of the Spanish Group for Hematopoietic Transplantation and Cell Therapy (GETH-TC)
4178Suppl. Files: 1196PDF: 1110Html: 246 -
Glucocorticoids and antivirals for HBV reactivation in onco-hematologic patients
994PDF: 579HTML: 2221Cover Letter: 208 -
SIMILARITIES OF ELDERLY AND THERAPY-RELATED AML
3729PDF: 920HTML: 6859 -
ANTIFUNGAL PROPHYLAXIS IN IMMUNOCOMPROMISED PATIENTS
4387PDF: 1405HTML: 2178 -
NOVEL DRUGS IN FOLLICULAR LYMPHOMA
5184PDF: 1550HTML: 1655Untitled: 246 -
UPDATE ON THE LABORATORY DIAGNOSIS OF INVASIVE FUNGAL INFECTIONS
2430PDF: 1448HTML: 2003 -
HEMATOPOIETIC CELL TRANSPLANTATION FOR OLDER PATIENTS WITH MDS
2103PDF: 787HTML: 3250 -
CAR-T CELLS IN CHRONIC LYMPHOCYTIC LEUKEMIA CAR-T and CLL
3787PDF: 1654HTML: 86







